Turkey: Healthcare

Turkey has significantly enhanced tax incentives for service exports by increasing the income deduction rate from 80% to 100% for qualifying services provided to non-resident clients.

The legal framework governing dietary supplements in Turkey imposes significant compliance obligations on manufacturers to protect public health. These responsibilities span from pre-market technical documentation and conformity declarations to post-market product traceability and corrective action implementation, making systematic compliance policies essential for sustainable trade in today's food sector.

Turkey's Named Patient Programs have evolved from emergency access mechanisms into structured regulatory frameworks requiring systematic clinical and pharmacoeconomic evidence generation.

Alternative reimbursement models in Türkiye are evolving to improve patient access to innovative medicines while managing healthcare costs.

Recent regulatory developments in Turkey's medical devices sector signal a fundamental shift toward enforcement-driven market discipline, with Law No. 7557 introducing expanded administrative sanctions targeting...

Turkey's Law No. 7557 introduces comprehensive healthcare reforms affecting physician practice limits, advertising restrictions, and pharmaceutical tracking systems.

On 19 January 2026, the Turkish Medicines and Medical Devices Agency announced a new initiative focusing on real-world data and pharmacoeconomic...

31.01.2026 tarihli ve 33154 sayılı Resmî Gazete'de Kenevir Yetiştiriciliği ve Kontrolüne Dair Yönetmelik ("Yetiştiricilik Yönetmeliği") ile Kenevirden Elde Edilen Ürünlere Dair Yönetmelik ("Ürün Yönetmeliği") yayımlanarak yürürlüğe girmiştir.

The Regulation on Cannabis Cultivation and Control ("Cultivation Regulation") and the Regulation on Products Derived from Cannabis ("Product Regulation") were published in the Official Gazette dated 31 January 2026 and numbered 33154, and have entered into force on the same date.